1. Home
  2. FHN vs BIO Comparison

FHN vs BIO Comparison

Compare FHN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Horizon Corporation

FHN

First Horizon Corporation

HOLD

Current Price

$22.10

Market Cap

10.4B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$264.91

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHN
BIO
Founded
1864
1952
Country
United States
United States
Employees
7400
7450
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FHN
BIO
Price
$22.10
$264.91
Analyst Decision
Buy
Strong Buy
Analyst Count
19
4
Target Price
$25.76
$358.50
AVG Volume (30 Days)
5.1M
254.4K
Earning Date
04-15-2026
04-30-2026
Dividend Yield
3.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.57
$2.74
Revenue Next Year
$4.19
$3.05
P/E Ratio
$13.42
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$15.23
$211.43
52 Week High
$26.56
$343.12

Technical Indicators

Market Signals
Indicator
FHN
BIO
Relative Strength Index (RSI) 39.71 41.88
Support Level $22.02 $254.98
Resistance Level $23.08 $264.68
Average True Range (ATR) 0.50 7.85
MACD 0.09 1.34
Stochastic Oscillator 46.51 28.93

Price Performance

Historical Comparison
FHN
BIO

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets. The Wholesale segment delivers industry-specific products and services, while the Corporate segment provides internal support functions like finance, risk, and audit.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: